SEC Form 4 · accession 0001171843-16-009880
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles H Sherwood
Officer — President, CEO, Director · Director
Period of report
May 6, 2016
Accepted (ET)
May 10, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 6, 2016 | G | 11,350 | $0.00 | D | 252,705 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of common stock of Anika Therapeutics, Inc. were given by Dr. Sherwood as a bona fide gift to the UMass Foundation, a 501(c)(3) non-profit organization, for no valuable consideration on May 6, 2016